688192 迪哲医药
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(463,308)(967,883)(603,373)(492,278)(410,012)
投资活动产生之现金流量净额(86,617)611,190384,556(1,627,300)(85,042)
筹资活动产生之现金流量净额606,803308,249(33,265)1,981,124814,604
汇率变动对现金及现金等价物的影响(248)9719,517(6,330)(17,404)
现金及现金等价物净增加/(减少)56,630(47,473)(242,564)(144,783)302,145
期初现金及现金等价物余额73,927121,399363,964508,747206,602
期末现金及现金等价物余额130,55773,927121,399363,964508,747